Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
1 clinical trials · Condition
◉ Watch Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma (NCT05363800) | Jiangsu HengRui Medicine Co., Ltd. | 2022-06-17 |
Track Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.